GSK And Technion Sign Drug Development Deal

– GlaxoSmithKline and BioRap will commercialize a treatment for lethal side effects of bone marrow transplants. – – Pharmaceutical giant GlaxoSmithKline plc (LSE: GSK) has signed a joint More...